EmailStory Stocks®
Archive
Last Update: 22-Mar-13 10:42 ET
The industrial sector is currently trading higher by +0.3%, in line with the S&P 500 in early trade
Earnings: Nothing of Interest.
Broker Actions: MPR +3.7% upgraded to Buy from Hold at Brean Capital. R +2.4% upgraded to Strong Buy from Outperform at Raymond James. USG +2.3% initiated with a Buy at Sun Trust Rbsn Humphrey. CW +1.0% initiated with a Buy at Ascendiant Capital Markets; tgt $41. ENOC -1.1% target raised to $21 at Needham.
News: ODFL +5.1% raises expectations for Q1 tonnage growth to range of 4.5% to 5.0% from previous range of 4.0% to 4.5%; affirms expectations for Q1 increase in rev per hundredweight, excluding fuel surcharge, in range of 2.5% to 3.0% WLT +2.8% commenced a $350 mln private offering of senior notes due 2021 FDX +0.9% has purchased Boeing (BA +0.7%) 757s From United (UAL +0.3%) in an effort to cut fuel costs, according to reports GE +0.1%: FDA approves GE Healthcare's AdreView for cardiac risk evaluation in heart failure patients.
Broker Actions: MPR +3.7% upgraded to Buy from Hold at Brean Capital. R +2.4% upgraded to Strong Buy from Outperform at Raymond James. USG +2.3% initiated with a Buy at Sun Trust Rbsn Humphrey. CW +1.0% initiated with a Buy at Ascendiant Capital Markets; tgt $41. ENOC -1.1% target raised to $21 at Needham.
News: ODFL +5.1% raises expectations for Q1 tonnage growth to range of 4.5% to 5.0% from previous range of 4.0% to 4.5%; affirms expectations for Q1 increase in rev per hundredweight, excluding fuel surcharge, in range of 2.5% to 3.0% WLT +2.8% commenced a $350 mln private offering of senior notes due 2021 FDX +0.9% has purchased Boeing (BA +0.7%) 757s From United (UAL +0.3%) in an effort to cut fuel costs, according to reports GE +0.1%: FDA approves GE Healthcare's AdreView for cardiac risk evaluation in heart failure patients.
